Henry C. Nathan

1.8k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Henry C. Nathan is a scholar working on Epidemiology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Henry C. Nathan has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 19 papers in Molecular Biology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Henry C. Nathan's work include Trypanosoma species research and implications (22 papers), Polyamine Metabolism and Applications (11 papers) and Research on Leishmaniasis Studies (10 papers). Henry C. Nathan is often cited by papers focused on Trypanosoma species research and implications (22 papers), Polyamine Metabolism and Applications (11 papers) and Research on Leishmaniasis Studies (10 papers). Henry C. Nathan collaborates with scholars based in United States. Henry C. Nathan's co-authors include Albert Sjoerdsma, Cyrus J. Bacchi, George H. Hitchings, S. H. Hutner, Carol Bacchi, P. P. McCann, Gertrude B. Elion, Peter P. McCann, Samuel Bieber and R. Wayne Rundles and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

Henry C. Nathan

32 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidase

1963 250 citations Gertrude B. Elion, Henry C. Nathan et al. Biochemical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry C. Nathan United States	21	732	712	398	303	142	34	1.4k
C. Giroud France	24	635 0.9×	1.2k 1.7×	979 2.5×	264 0.9×	233 1.6×	53	2.0k
Julian J. Jaffe United States	21	681 0.9×	303 0.4×	176 0.4×	183 0.6×	187 1.3×	85	1.4k
Allen B. Clarkson United States	19	374 0.5×	603 0.8×	347 0.9×	108 0.4×	95 0.7×	32	977
Simon A. Osborne United Kingdom	20	628 0.9×	416 0.6×	425 1.1×	360 1.2×	106 0.7×	42	1.5k
Larry W. Hardy United States	19	1.2k 1.6×	425 0.6×	446 1.1×	316 1.0×	50 0.4×	36	1.7k
Robert T. Jacobs United States	27	755 1.0×	515 0.7×	413 1.0×	625 2.1×	135 1.0×	43	1.9k
Casimir Blonski France	17	580 0.8×	261 0.4×	169 0.4×	323 1.1×	59 0.4×	50	1.1k
John J. McCormack United States	25	702 1.0×	204 0.3×	134 0.3×	352 1.2×	30 0.2×	80	1.5k
M. Earl Balis United States	28	1.6k 2.2×	524 0.7×	138 0.3×	99 0.3×	42 0.3×	124	2.3k
Renée Lira Venezuela	12	358 0.5×	699 1.0×	601 1.5×	414 1.4×	104 0.7×	17	1.1k

Countries citing papers authored by Henry C. Nathan

Since Specialization

Citations

This map shows the geographic impact of Henry C. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry C. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry C. Nathan more than expected).

Fields of papers citing papers by Henry C. Nathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry C. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry C. Nathan. The network helps show where Henry C. Nathan may publish in the future.

Co-authorship network of co-authors of Henry C. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of Henry C. Nathan. A scholar is included among the top collaborators of Henry C. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry C. Nathan. Henry C. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yarlett, Nigel, Burt Goldberg, Henry C. Nathan, Joanne Garofalo, & Cyrus J. Bacchi. (1991). Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in Vitro lysis by arsenicals. Experimental Parasitology. 72(2). 205–215. 30 indexed citations

Kini, Ganesh D., Roland K. Robins, Steven B. Larson, et al.. (1990). Synthesis, structure, and antiparasitic activity of sulfamoyl derivatives of ribavirin. Journal of Medicinal Chemistry. 33(1). 44–48. 24 indexed citations

Bacchi, Cyrus J., et al.. (1990). Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrobial Agents and Chemotherapy. 34(6). 1183–1188. 65 indexed citations

Nathan, Henry C., et al.. (1984). Antitumor Phthalanilides Active in Acute and Chronic Trypanosoma Brucei Brucei Murine Infections. American Journal of Tropical Medicine and Hygiene. 33(5). 845–850. 2 indexed citations

Clarkson, Allen B., E. Jay Bienen, Cyrus J. Bacchi, et al.. (1984). New Drug Combination for Experimental Late-Stage African Trypanosomiasis: DL-α-Difluoromethylornithine (DFMO) with Suramin. American Journal of Tropical Medicine and Hygiene. 33(6). 1073–1077. 41 indexed citations

Bacchi, Cyrus J., Joanne Garofalo, Peter P. McCann, et al.. (1983). In vivo effects of α-dl-Difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei. Molecular and Biochemical Parasitology. 7(3). 209–225. 113 indexed citations

Nathan, Henry C., et al.. (1982). In Vivo and In Vitro Activity by Diverse Chelators against Trypanosoma brucei brucei1. The Journal of Protozoology. 29(1). 85–90. 16 indexed citations

Nathan, Henry C., et al.. (1981). Bleomycin-induced life prolongation of mice infected with Trypanosoma brucei brucei EATRO 110. Transactions of the Royal Society of Tropical Medicine and Hygiene. 75(3). 394–398. 7 indexed citations

Bacchi, Cyrus J., Henry C. Nathan, Seymour H. Hutner, David S. Duch, & Charles A. Nichol. (1981). Prevention by polyamines of the curative effect of amicarbalide and imidocarb for Trypanosoma brucei infections in mice. Biochemical Pharmacology. 30(8). 883–886. 25 indexed citations

10.

Nathan, Henry C., et al.. (1981). Antagonism by polyamines of the curative effects of α-difluoromethylornithine in Trypanosoma brucei brucei infections. Biochemical Pharmacology. 30(21). 3010–3013. 35 indexed citations

11.

McCann, Peter P., Cyrus J. Bacchi, A B Clarkson, et al.. (1981). Further studies on difluoromethylornithine in African trypanosomes.. PubMed. 59(5-6). 434–40. 41 indexed citations

12.

Bacchi, Carol, Henry C. Nathan, S. H. Hutner, P. P. McCann, & Albert Sjoerdsma. (1980). Polyamine Metabolism: A Potential Therapeutic Target in Trypanosomes. Science. 210(4467). 332–334. 302 indexed citations

13.

Bacchi, Cyrus J., Gregg Y. Lipschik, & Henry C. Nathan. (1977). Polyamines in trypanosomatids. Journal of Bacteriology. 131(2). 657–661. 30 indexed citations

14.

Nathan, Henry C., et al.. (1974). Inventaires piagetiens : Recueil des expériences de Jean Piaget. Medical Entomology and Zoology.

15.

Siegel, S. M., Henry C. Nathan, & Karen Roberts. (1968). EXPERIMENTAL BIOLOGY OF AMMONIA-RICH ENVIRONMENTS: OPTICAL AND ISOTOPIC EVIDENCE FOR VITAL ACTIVITY IN Penicillium IN LIQUID AMMONIA-GLYCEROL MEDIA AT -40°C. Proceedings of the National Academy of Sciences. 60(2). 505–508. 6 indexed citations

16.

Elion, Gertrude B., et al.. (1963). Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidase. Biochemical Pharmacology. 12(1). 85–93. 250 indexed citations breakdown →

17.

Hitchings, George H., Henry C. Nathan, & Gertrude B. Elion. (1962). Comparative antitumor and anti-immune effects. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 116. 1 indexed citations

18.

Nathan, Henry C., et al.. (1961). Detection of Agents which Interfere with the Immune Response. Experimental Biology and Medicine. 107(4). 796–799. 82 indexed citations

19.

Elion, Gertrude B., Samuel Bieber, Henry C. Nathan, & George H. Hitchings. (1958). Uracil antagonism and inhibition of mammary adenocarcinoma 755.. PubMed. 18(7). 802–17. 31 indexed citations

20.

Balis, M. Earl, Daniel H. Levin, George Bosworth Brown, et al.. (1957). The effects of 6-mercaptopurine on Lactobacillus casei. Archives of Biochemistry and Biophysics. 71(2). 358–366. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact